BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38334450)

  • 1. ASB3 promotes hepatocellular carcinoma progression by mediating DR5 ubiquitination in TRAIL resistance.
    Huang L; Che Z; Liu F; Ge M; Wu Z; Wu L; Chen W; Wang Z; Zhu Z; Xu W; Dong Q; Yang D
    FASEB J; 2024 Feb; 38(4):e23475. PubMed ID: 38334450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ankyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor II.
    Chung AS; Guan YJ; Yuan ZL; Albina JE; Chin YE
    Mol Cell Biol; 2005 Jun; 25(11):4716-26. PubMed ID: 15899873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
    Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X
    J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.
    Pellerito O; Calvaruso G; Portanova P; De Blasio A; Santulli A; Vento R; Tesoriere G; Giuliano M
    Mol Pharmacol; 2010 May; 77(5):854-63. PubMed ID: 20159939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL enhances apoptosis of human hepatocellular carcinoma cells sensitized by hepatitis C virus infection: therapeutic implications.
    Jang JY; Kim SJ; Cho EK; Jeong SW; Park EJ; Lee WC; Lee SH; Kim SG; Kim YS; Kim HS; Kim BS; Lin W; Chung RT
    PLoS One; 2014; 9(6):e98171. PubMed ID: 24927176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells.
    Zhang YY; Feng PP; Wang HF; Zhang H; Liang T; Hao XS; Wang FZ; Fei HR
    Chem Biol Interact; 2022 Sep; 365():110076. PubMed ID: 35948134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camptothecin sensitizes human hepatoma Hep3B cells to TRAIL-mediated apoptosis via ROS-dependent death receptor 5 upregulation with the involvement of MAPKs.
    Jayasooriya RG; Choi YH; Hyun JW; Kim GY
    Environ Toxicol Pharmacol; 2014 Nov; 38(3):959-67. PubMed ID: 25461556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5, 7-Dimethoxyflavone sensitizes TRAIL-induced apoptosis through DR5 upregulation in hepatocellular carcinoma cells.
    Yang JF; Cao JG; Tian L; Liu F
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):195-206. PubMed ID: 21660448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interleukin-12 enhanced tumor necrosis factor related apoptosis-inducing ligand TRAIL-induced apoptosis in human hepatocellular carcinoma by inhibiting expression of survivin].
    He SQ; Chen Y; Chen XP; Zhang WG; Wang HP; Zhang BX
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):453-7. PubMed ID: 12895357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.
    Song P; Yang S; Hua H; Zhang H; Kong Q; Wang J; Luo T; Jiang Y
    J Biol Chem; 2019 Apr; 294(15):5945-5955. PubMed ID: 30782845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASB3 knockdown promotes mitochondrial apoptosis via activating the interdependent cleavage of Beclin1 and caspase-8 in hepatocellular carcinoma.
    Zhang W; Liu F; Che Z; Wu M; Tang Z; Liu J; Yang D
    Sci China Life Sci; 2019 Dec; 62(12):1692-1702. PubMed ID: 31016535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on effect and mechanism of Honokiol enhancing tumor necrosis factor-related apoptosis inducing ligand against hepatocellular carcinoma HepG2 cells via activating JNK signaling pathway].
    Xiao G; Yang R; Dang L; Dong CL
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):441-445. PubMed ID: 30317758
    [No Abstract]   [Full Text] [Related]  

  • 14. Sensitization of TRAIL-induced cell death by 20(S)-ginsenoside Rg3 via CHOP-mediated DR5 upregulation in human hepatocellular carcinoma cells.
    Lee JY; Jung KH; Morgan MJ; Kang YR; Lee HS; Koo GB; Hong SS; Kwon SW; Kim YS
    Mol Cancer Ther; 2013 Mar; 12(3):274-85. PubMed ID: 23053497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutlin-3 Promotes TRAIL-Induced Liver Cancer Cells Apoptosis by Activating p53 to Inhibit bcl-2 and Surviving Expression.
    Zhang C; Ni J; Fan W; Hou J
    Ann Clin Lab Sci; 2022 Jul; 52(4):601-610. PubMed ID: 36197780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of soluble TRAIL in human hepatocellular carcinoma.
    He S; Chen Y; Chen X; Zhao Y; Wang H; Zhang W; Wang S
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(1):51-4. PubMed ID: 15934308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteins.
    Subramaniam A; Loo SY; Rajendran P; Manu KA; Perumal E; Li F; Shanmugam MK; Siveen KS; Park JI; Ahn KS; Hui KM; Kumar AP; Sethi G
    Apoptosis; 2013 Oct; 18(10):1175-87. PubMed ID: 23700228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsaicin sensitizes TRAIL-induced apoptosis through Sp1-mediated DR5 up-regulation: involvement of Ca(2+) influx.
    Moon DO; Kang CH; Kang SH; Choi YH; Hyun JW; Chang WY; Kang HK; Koh YS; Maeng YH; Kim YR; Kim GY
    Toxicol Appl Pharmacol; 2012 Feb; 259(1):87-95. PubMed ID: 22200406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation.
    Luan Z; He Y; He F; Chen Z
    Mol Med Rep; 2015 Jan; 11(1):203-11. PubMed ID: 25333816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROS-dependent ER-stress.
    Moon DO; Park SY; Choi YH; Ahn JS; Kim GY
    Biochem Pharmacol; 2011 Dec; 82(11):1641-50. PubMed ID: 21903093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.